---
title: 'App-Controlled Treatment Monitoring and Support for Patients With Head and
  Neck Cancer Undergoing Radiotherapy: Results From a Prospective Randomized Controlled
  Trial'
date: '2023-10-19'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37856185/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231019180803&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: This trial demonstrated the feasibility of incorporating
  daily app-based ePRO surveillance for patients with HNC undergoing radiotherapy.
  Our data, for the first time, demonstrate that telemonitoring in this setting led
  to increased reporting of HNC-specific symptom burden and significantly improved
  several domains of patient satisfaction. Further analyses are needed to assess whether
  our findings hold true outside the context of a clinical ...'
disable_comments: true
---
CONCLUSIONS: This trial demonstrated the feasibility of incorporating daily app-based ePRO surveillance for patients with HNC undergoing radiotherapy. Our data, for the first time, demonstrate that telemonitoring in this setting led to increased reporting of HNC-specific symptom burden and significantly improved several domains of patient satisfaction. Further analyses are needed to assess whether our findings hold true outside the context of a clinical ...